secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyell Immunopharma, Inc. (LYEL)
CIK:        0001806952
Form:       8-K
Filed at:   2023-06-06T23:59:59+00:00
Accession:  0001193125-23-161594
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lyell Immunopharma CLO Rahsaan Thompson resigns, effective June 16, 2023
------------------------------------------------------------------------

- Rahsaan Thompson to step down as Chief Legal Officer on June 16, 2023; no disagreement cited.
- Will provide transition services as independent contractor through Sep 29, 2023, unless earlier terminated.
- Severance includes $565,233 cash (base salary plus prorated bonus) paid over 12 months, COBRA subsidy up to 12 months.
- Signing bonus repayment of $150,000 waived; stock options continue vesting until end date, exercise period extended to June 30, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1806952/000119312523161594/0001193125-23-161594-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1806952/000119312523161594/d506460d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-161594

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer